AUTM Takes Center Stage at Global Bio-India 2024

AUTM continues to solidify its position as a global leader in technology transfer, with its recent participation at the Global Bio-India (GBI) 2024 conference. Held in New Delhi, India, from September 12-14, the event focused on fostering the 'Biotech Innovation Ecosystem' and advancing 'Bio-manufacturing'. Global Bio-India 2024 attracted more than 8,000 delegates from around the world, bridging the Indian biotechnology ecosystem with international counterparts.

The gathering featured a diverse range of stakeholders, including representatives from industry, startups, SMEs, central and state governments, academic and research institutions, incubation centers, investors and national and international associations.

Joy Goswami, Senior Director of Corporate Engagement at The Johns Hopkins University’s Whiting School of Engineering and Chair-Elect of AUTM, was invited to speak at two key technical sessions during GBI 2024. His expertise in technology transfer and intellectual property was invaluable in contributing to discussions on accelerating biotransformation and navigating the complexities of public-private partnerships (PPPs).

Goswami spoke on “Accelerating Biotransformation: Navigating Technology Access, Co-Creation, and Licensing to Realize the Potential of Biomanufacturing in India” and “Tech Transfer & IP Steering Socio-Economic Impact”. These sessions brought together leading industry professionals, researchers, policymakers and legal experts to explore best practices for adopting breakthrough technologies, overcoming licensing challenges and navigating complex legal and intellectual property issues in public-private partnerships. Additionally, the discussions highlighted the crucial role of government in facilitating effective technology transfer, promoting innovation and driving socio-economic impact.

Goswami's participation at GBI 2024 highlights AUTM's growing influence in the international technology transfer community. As a leading organization dedicated to supporting the commercialization of academic research, AUTM is actively working to bridge the gap between research and the marketplace.

“It was an honor to participate in Global Bio-India 2024 and contribute to discussions on such important topics,” said Goswami. “India is a rapidly growing economy with immense potential for biotech innovation. By fostering collaboration and addressing key challenges, we can accelerate the development of new technologies and improve the lives of people around the world.”

The event provided a platform for AUTM to showcase its expertise and connect with key stakeholders in the Indian biotechnology ecosystem. By participating in discussions on technology access, co-creation, licensing, and intellectual property, AUTM helped to advance the field of biomanufacturing and drive innovation.

AUTM's involvement in GBI 2024 is a testament to its commitment to fostering global collaboration and promoting the commercialization of academic research. As the organization continues to expand its reach and influence, it is poised to play an even greater role in shaping the future of technology transfer worldwide.